SINGAPORE (Aug 7): Raffles Medical Group recently obtained regulatory approvals to enter into the Integrated Shield market, officially launching Raffles Shield, on Aug 1.
“We understand from management that interest for this product is healthy, and it is possible to expect incremental revenue of S$10 [million]–S$12.5 million per annum as a result of this,” says OCBC analyst Joseph Ng in a Tuesday report.
On a long-term basis, net margins are expected to be about 5%, while that of...(click on link for full story on theedgesingapore.com)